Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14930544 | 0.75 | TSHR (0.32) | ALDH1A1 | |
| SCHEMBL6797037 | 0.74 | DPP4 (0.33) | DPP4 | |
| SCHEMBL14926787 | 0.74 | TSHR (0.31) | ALDH1A1 | |
| SCHEMBL10207219 | 0.72 | CA12 (0.31) | — | |
| SCHEMBL1281593 | 0.72 | TSHR (0.36) | ALDH1A1 | |
| SCHEMBL1281592 | 0.72 | TSHR (0.36) | ALDH1A1 | |
| SCHEMBL7603110 | 0.69 | TSHR (0.37) | ALDH1A1 | |
| SCHEMBL1074609 | 0.68 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL3861415 | 0.68 | — | — | |
| Acetic Acid SCHEMBL27987775 | 0.67 | ALDH1A1 (0.35) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040033940-A1 | Antitumor activity | PHARMA MAR, S.A. | 2004-02-19 | — | — | US | disclosed |
| EP-0894092-B8 | A CYCLIC HEPTA-PEPTIDE DERIVATIVE FROM COLONIAL ASCIDIANS, LISSOCLINUM SP. | PHARMA MAR SA (ES) | 2002-10-09 | — | — | EP | disclosed |
| EP-0894092-B1 | A CYCLIC HEPTA-PEPTIDE DERIVATIVE FROM COLONIAL ASCIDIANS, LISSOCLINUM SP. | PHARMA MAR SA (ES) | 2002-04-03 | — | — | EP | disclosed |
| US-6025466-A | WITH ANTITUMOR ACTIVITY | PHARMA MAR, S.A. (ES) | 2000-02-15 | — | — | US | disclosed |
| EP-0894092-A1 | A CYCLIC HEPTA-PEPTIDE DERIVATIVE FROM COLONIAL ASCIDIANS, LISSOCLINUM SP. | PHARMA MAR, S.A. (ES) | 1999-02-03 | — | — | EP | disclosed |
| WO-1997039025-A1 | A CYCLIC HEPTA-PEPTIDE DERIVATIVE FROM COLONIAL ASCIDIANS, LISSOCLINUM SP. | PHARMA MAR, S.A. (ES) | 1997-10-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040033940-A1 | Antitumor activity | TK1, MCTS1, TLK2 | ALDH1A1 4611/4885DPP4 2129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.